Baird notes Elevance Health (ELV) pre-announced a Q1 earnings beat with adjusted EPS of $11.97 vs. $11.62 implied guide, vs. $11.32 street, vs. its $11.63. The company cites medical costs ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024 and earned $45 billion in revenue in the quarter. For full-year 2024, Elevance reported $175.2 billion in revenue, an ...

Shares of ELV opened at $424.44 on Tuesday. The company’s fifty day moving average is $416.11 and its 200 day moving average is $411.67. The company has a debt-to-equity ratio of 0.71, a quick ...

Elevance Health will beat its earnings guidance for the first quarter despite high Medicare Advantage costs, the company announced Thursday. The health insurer reported that while Medicare ...

Elevance Health (NYSE:ELV) on Thursday issued its preliminary financial results for Q1 2025, projecting $9.61 of GAAP net income and $11.97 of non-GAAP net income on a diluted per share basis ...

ELEVANCE HEALTH ($ELV) is expected to release its quarterly earnings data on Tuesday, April 22nd before market open, per Finnhub. Analysts are expecting revenue of ...

Elevance Health said medical-cost trends played out as expected in the first quarter, contrasting with a disappointing quarterly report from UnitedHealth Group. The Indianapolis insurer is set to ...

announces a comprehensive rebrand… InfoWorks launches new Strategy and Design Practice that will de-risk the development of innovative… How Nashville's signature industry is transforming ...

Shares of CVS, Humana, Elevance and other health insurance companies may be trading lower after UnitedHealth reported earnings, as investors assess the health insurance industry as a whole.